<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000340935"><TermName>ravuconazole</TermName><TermPronunciation>(RA-vuh-KAH-nuh-zole)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of infections caused by fungi. It belongs to the family of drugs called antifungal agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731359" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ravuconazole&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731358" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ravuconazol&quot;" language="es" id="_4"/><SpanishTermName>ravuconazol</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de infecciones causadas por hongos. Pertenece al tipo de medicamentos llamados antifúngicos o antimicóticos.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-10-25</DateFirstPublished><DateLastModified>2005-01-20</DateLastModified></GlossaryTerm>
